CAREX
Price
$21.36
Change
-$0.10 (-0.47%)
Updated
Jun 26 closing price
Net Assets
55.26M
CSPAX
Price
$82.90
Change
-$0.46 (-0.55%)
Updated
Jun 26 closing price
Net Assets
91.47B
Interact to see
Advertisement

CAREX vs CSPAX

CAREX vs CSPAX Comparison Chart in %
View a ticker or compare two or three
VS
CAREX vs. CSPAX commentary
Jun 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAREX is a StrongBuy and CSPAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSPAX has more cash in the bank: 91.5B vs. CAREX (55.3M). CSPAX pays higher dividends than CAREX: CSPAX (0.62) vs CAREX (0.00). CAREX was incepted earlier than CSPAX: CAREX (6 years) vs CSPAX (24 years). CAREX (2.05) is less costly to investors than CSPAX (1.04). CAREX is a more actively managed with annual turnover of: 64.00 vs. CSPAX (41.00). CSPAX has a lower initial minimum investment than CAREX: CSPAX (250) vs CAREX (2500). CAREX annual gain was more profitable for investors over the last year : 30.60 vs. CSPAX (18.02). CAREX return over 5 years is better than : 14.40 vs. CSPAX (-3.82).
CAREXCSPAXCAREX / CSPAX
Total Expense Ratio1.301.04125%
Annual Report Gross Expense Ratio2.051.04197%
Fund Existence6 years24 years-
Gain YTD18.96315.123125%
Front LoadN/A4%-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets55.3M91.5B0%
Annual Yield % from dividends0.000.62-
Returns for 1 year30.6018.02170%
Returns for 3 years60.3139.13154%
Returns for 5 years14.40-3.82-377%
Returns for 10 years195.31102.84190%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTNX21.510.09
+0.42%
Artisan Select Equity Investor
FCUEX20.260.05
+0.25%
NYLI PineStone U.S. Equity Class A
TWUIX102.680.25
+0.24%
American Century Ultra® I
DLCFX17.030.02
+0.12%
Destinations Large Cap Equity I
JGECX13.26N/A
N/A
JHancock Global Equity C